Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:46:26.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual content with an error message and a Home button. This indicates restricted access to the record rather than an update to the trial data.
    Difference
    17%
    Check dated 2026-09-22T22:39:02.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a system/template update rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-15T20:34:18.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a small update to the page’s versioning. This change does not alter any study details, eligibility criteria, or other user-visible content.
    Difference
    0.0%
    Check dated 2026-09-01T19:15:09.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, signaling an NIH grant/contract reference associated with the trial. This addition expands the funding/administrative attribution attached to the study record.
    Difference
    0.0%
    Check dated 2026-08-25T20:22:29.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a new release of the documentation. This likely reflects small corrections or minor updates since the previous version.
    Difference
    0.0%
    Check dated 2026-08-11T22:06:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.